NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed exclusive rights to a patent portfolio covering the optimization of the stem cell differentiation selection process and the use of heart cells in drug testing.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.
Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.
FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.
Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.